51
Views
11
CrossRef citations to date
0
Altmetric
Review

Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer

&
Pages 1091-1101 | Published online: 10 Jan 2014

References

  • Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J. Clin.57(1), 43–66 (2007).
  • Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol.19, 666–675 (2001)
  • Prout G, Marshall VF. The prognosis with untreated bladder tumors. Cancer9, 551–558 (1956).
  • Vieweg J, Gschwend JE, Herr HW, Fair WR. The impact of primary stage on the survival in patients with lymph node positive bladder cancer. J. Urol.161, 72–76 (1999).
  • Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today- a homogenous series without neoadjuvant therapy. J. Clin. Oncol.21, 690–696 (2003).
  • Poulsen AL, Horn T, Steven K. Radical cystectomy: Extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J. Urol.160, 2015–2020 (1998).
  • Hautmann RE, Gschwend JE, de Petriconi RC, Kron M, Volkmer BG. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J. Urol.176, 486–492 (2006).
  • Ghoneim MA, El-Mekresh MM, El-Baz MA, el-Attar IA, Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J. Urol.158, 393–399 (1997).
  • Halsted W. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1898–January 1894. Johns Hopkins Hosp. Bull.4, 297 (1894).
  • Wagner M, Sokoloff M, Daneshmand S. The role of pelvic lymphadenectomy for prostate cancer – therapeutic? J. Urol.179(2), 408–413 (2008).
  • Terrone C, Guercio S, DeLuca S et al. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. GJU Int.91, 37–40 (2003).
  • Skinner EC, Stein JP, Skinner DG. Surgical benchmarks for the treatment of invasive bladder cancer. Urol.Onc.: Seminars and Original investigations.25, 66–71 (2007).
  • Herr HW, Lee C, Chang S, Lerner SP. Standardization of the radical cystectomy and pelvic lymph node dissection from bladder cancer: a collaborative group report. J. Urol.171, 1823–1828 (2004).
  • Herr HW, Faulkner JR, Grossamn HB et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J. Clin. Onc.22, 2781–2789 (2004).
  • Konety BR, Joslyn SA, O’Donnell M. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program database. J. Urol.169, 946–950 (2003).
  • Smith JA, Whitmore WF. Regional lymph node metastasis from bladder cancer. J. Urol.126, 591–593 (1981).
  • Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP. Stage specific lymph node metastasis mapping radical cystectomy specimens. J. Urol.171, 1830–1834 (2004).
  • Leissner J, Ghoneim A, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J. Urol.171, 139–144 (2004).
  • Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J. Urol.172, 1286–1290 (2004).
  • Abol-Enein H, El-Baz M, Abd El-Hameed MA, Abdel-Latif M, Ghoneim MA. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J. Urol.172, 1818–1821 (2004).
  • Mills RD, Turner H, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J. Urol.166, 19–23 (2001).
  • Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: the concept of lymph node density. J. Urol.170, 35–41 (2003).
  • Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J.Urol.166, 2295–2296 (2001).
  • Stein JP, Penson DF, Cai J et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J.Urol.177, 876–882 (2007).
  • Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J.Urol.167, 1295–1298 (2002).
  • Leissner J, Hohenfellner R, Thurhoff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int.85, 817–823 (2000).
  • Herr HW. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology61, 105–108 (2003).
  • Dhar BN, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J. Urol.179, 873–878 (2008).
  • Steven K, Poulsen AL. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastatis above the bifurcation of the common iliac vessels treated with surgery only. J. Urol.178, 1218–122 (2007).
  • Brössner C, Pycha A, Toth A, Mian C, Kuber W. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int.93, 64–66 (2004).
  • Vieweg J, Gschwend JG, Herr HW, Fair WR. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol.161, 449–454 (1999).
  • Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J. Urol.176, 53–57 (2006).
  • Lerner SP, Skinner DG, Lieskovsky G et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J. Urol.149, 758–765 (1993).
  • Greene FL; American Joint Committee on Cancer; American Center Society. Greene FL, Page DL, Fleming ID et al. (Eds). AJCC Cancer Staging Manual (6th Edition). Springer, NY, USA (2002).
  • Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J. Urol.169, 943–945 (2003).
  • Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J. Clin. Oncol.23, 2358–2365 (2005).
  • Herr HW. The concept of lymph node density – is it ready for clinical practice? J. Urol.177, 1273–1276 (2007).
  • Kassouf W, Agarwal PK, Herr HW et al. Lymph node density is superior to TNM nodal status in predicting disease specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J. Clin. Oncol.26, 121–126 (2008).
  • Park J, Park S, Song C et al. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy. Urology70, 257–262 (2007).
  • Skinner DG, Daniles JR, Russell CA et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J. Urol.145, 459–467 (1991).
  • Studer UE, Bacchi M, Biedermann C et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J. Urol.152, 81–84 (1994).
  • Freiha F, Reese J, Torti FM. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J. Urol.55 (2), 495–499 (1996).
  • Bono AV, Benvenuti C, Gibba A et al. Adjuvant chemotherapy in locally advanced bladder cancer. Final analysis of a controlled multicentre study. Acta. Urol. Ital.11, 5–8 (1997).
  • Einstein AB, Shipley W, Coombs J, Cummings KB, Soloway MS, Hawkings I. Cisplatin as adjunctive treatment for invasive bladder carcinoma: Tolerance and toxicities. Urology.23, 110–117 (1984).
  • Stockle M, Meyenburg W, Wellek S et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy results of a controlled prospective study. J. Urol.148, 302–307 (1992).
  • Sylvester R, Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. Ann. Oncol.11, 851–856 (2000).
  • Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur. Urol.48(2), 189–201 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.